Reduce blood culture contamination
Steripath® Gen2 is a unique Initial Specimen Diversion Device, supported by independent published clinical trial results of 12-month sustained rates as low as 0.2% in the ED. With improved test results, patients can benefit from reduced risk of sepsis misdiagnoses and unnecessary antibiotic treatment.
A Contaminated Blood Culture
Blood culture collection remains the gold standard for diagnosing bloodstream infections and sepsis– the leading cause of death and readmission in US hospitals. Even with best practices, between 35-50% of positive blood culture results are contaminated, resulting in false-positive diagnoses that place over one million lives at risk each year.
Even current best practices are susceptible to:
Human Factors
Risk of contamination during assembly and preparation of supplies, and skin prep
Skin Flora
You can disinfect but not sterilize the skin; up to 20% of skin flora remains viable in the keratin layer of the skin even after skin prep
Skin Plugs
Skin plugs, when present, will always enter the blood culture specimen bottle and commonly will contain microorganisms
Technology & Features
PROPRIETARY
Initial Specimen Diversion Mechanism
diverts and sequesters the initial (potentially contaminated) specimen into the isolation chamber
PROPRIETARY
Specimen Isolation Chamber
ensures sequestered contaminants are isolated from the blood culture specimen
PROPRIETARY
User-Controlled Diversion
enables necessary adjustments for “hard stick” patients with low venous pressure through negative pressure
PROPRIETARY
Independent, Sterile Flow Path
completion of diversion automatically opens an independent flow path for specimen collection
Comes Preassembled & Sterile
to eliminate touch-point contamination
The Benefits
of Accurate Blood Cultures
Reuce Patient Safety Risks
- Reduce the risk of C. Diff & antibiotic-resistant infections by decreasing unecessary antibiotic usage
- Reduce the risk of HAC/HAIs due to unnecessarily extended length of stay
Drive Antibiotic Stewardship
- Reduce broad-spectrum antibiotic use
- Supports compliance with federal and state mandates to reduce inappropriate antibiotic usage
Reduce Hospital Costs
Avoid non-reimbursable costs for:
- Additional procedures, clinical coordination and length of stay
- Unnecessary antibiotics, HAI/HAC events
Impact Quality Outcome Measures
- Positively impact key CMS quality outcome metrics including reduced C. Diff. & HAI occurrences
- Reduce false reporting for CLABSIs by significantly reducing false-positive blood culture test results
Steripath is available in multiple configurations
Blood culture collection is possible through peripheral sticks and initial IV starts with available extensions. It is also compatible with standard blood collection tubes and culture bottles made by BD, bioMerieux and certain Thermo Scientific products.
Available Extensions
Available Transfer Adapters
We’re with you, every step of the way
Our Clinical Partnership Includes:
• Pre-training and logistics including implementation planning meetings and online training
• Initial onsite implementation including train-the-trainer programs, sharing best practices, demonstrations, coaching, and training certifications
• Post-training resources including ongoing online training, onsite education, and retention modules
• Ongoing clinical support including tracking, reporting, compliance programs, root cause analysis, and clinical reviews
Money Back Guarantee
If you do not achieve a 50% or greater sustained reduction in blood culture contamination, you get your money back.